Literature DB >> 29536123

[Staging of oropharyngeal carcinomas : New TNM classification as a challenge for head and neck cancer centers].

A Beltz1, D Gösswein1, S Zimmer2, R H Stauber1, J Hagemann1, S Strieth1, C Matthias1, J Künzel3.   

Abstract

BACKGROUND: The TNM (tumor, nodes, metastasis) classification is updated periodically according to the literature and international recommendations. With the 8th edition, notable changes have been developed especially with regard to oropharyngeal cancer.
MATERIALS AND METHODS: The modifications as well as the practicability of the classification for staging of oropharyngeal cancers are demonstrated on the basis of cases from the tumor database.
RESULTS: The latest edition of the TNM classification realizes requirements to differentiate between human papilloma virus (HPV) positive and HPV-negative tumors during staging. Furthermore, the prognostic relevance of extranodal extension of lymph node metastases was integrated into the classification. While downstaging is performed regarding N category and Union Internationale Contre le Cancer (UICC) stage in many p16-positive tumors, for p16-negative tumors, extranodal spread mostly leads to a notable upstaging. Due to limited specificity of the p16 immunostaining, the relevance of false positive results has to be underlined. Missing integration of smoking behavior, limited standardization of the extranodal extension examination technique, as well as high demands on the documentation quality should be kept in mind.
CONCLUSION: Clinical trials will have to show whether deescalation strategies regarding p16-positive carcinomas are supported by the changes made in the TNM staging system. A prospective multicenter study should examine the universal applicability, the appropriateness for all sublocations, as well as the prognostic significance of the current edition.

Entities:  

Keywords:  Extranodal extension; HPV DNA tests; Head and neck neoplasms; Papillomaviridae; p16 immunhistochemistry

Mesh:

Year:  2018        PMID: 29536123     DOI: 10.1007/s00106-018-0499-0

Source DB:  PubMed          Journal:  HNO        ISSN: 0017-6192            Impact factor:   1.284


  25 in total

1.  Re: Extracapsular tumor extension in cervical lymph nodes: reconciling the literature and seer data.

Authors:  Wouter L Lodder; Michiel W M van den Brekel
Journal:  Head Neck       Date:  2011-10-17       Impact factor: 3.147

Review 2.  [The 8th edition of the AJCC Cancer Staging Manual : Updates in otorhinolaryngology, head and neck surgery].

Authors:  J Doescher; J A Veit; T K Hoffmann
Journal:  HNO       Date:  2017-12       Impact factor: 1.284

3.  Lymph node ratio as a valuable additional predictor of outcome in selected patients with oral cavity cancer.

Authors:  Julian Künzel; Konstantinos Mantsopoulos; Georgios Psychogios; Philipp Grundtner; Michael Koch; Heinrich Iro
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol       Date:  2014-03-12

4.  Human papillomavirus and rising oropharyngeal cancer incidence in the United States.

Authors:  Anil K Chaturvedi; Eric A Engels; Ruth M Pfeiffer; Brenda Y Hernandez; Weihong Xiao; Esther Kim; Bo Jiang; Marc T Goodman; Maria Sibug-Saber; Wendy Cozen; Lihua Liu; Charles F Lynch; Nicolas Wentzensen; Richard C Jordan; Sean Altekruse; William F Anderson; Philip S Rosenberg; Maura L Gillison
Journal:  J Clin Oncol       Date:  2011-10-03       Impact factor: 44.544

Review 5.  Extracapsular spread in head and neck squamous cell carcinoma: A systematic review and meta-analysis.

Authors:  Maxime Mermod; Genrich Tolstonog; Christian Simon; Yan Monnier
Journal:  Oral Oncol       Date:  2016-10-18       Impact factor: 5.337

6.  Observer variation in the histopathologic assessment of extranodal tumor spread in lymph node metastases in the neck.

Authors:  Michiel W M van den Brekel; Wouter L Lodder; Herbert V Stel; Elisabeth Bloemena; C René Leemans; Isaäc van der Waal
Journal:  Head Neck       Date:  2011-08-24       Impact factor: 3.147

7.  Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial.

Authors:  Carole Fakhry; William H Westra; Sigui Li; Anthony Cmelak; John A Ridge; Harlan Pinto; Arlene Forastiere; Maura L Gillison
Journal:  J Natl Cancer Inst       Date:  2008-02-12       Impact factor: 13.506

Review 8.  Head and Neck Squamous Cell Carcinoma: Update on Epidemiology, Diagnosis, and Treatment.

Authors:  Shanthi Marur; Arlene A Forastiere
Journal:  Mayo Clin Proc       Date:  2016-03       Impact factor: 7.616

9.  Eurogin Roadmap: comparative epidemiology of HPV infection and associated cancers of the head and neck and cervix.

Authors:  Maura L Gillison; Xavier Castellsagué; Anil Chaturvedi; Marc T Goodman; Peter Snijders; Massimo Tommasino; Marc Arbyn; Silvia Franceschi
Journal:  Int J Cancer       Date:  2013-08-05       Impact factor: 7.396

10.  Pathology-based staging for HPV-positive squamous carcinoma of the oropharynx.

Authors:  B H Haughey; P Sinha; D Kallogjeri; R L Goldberg; J S Lewis; J F Piccirillo; R S Jackson; E J Moore; M Brandwein-Gensler; S J Magnuson; W R Carroll; T M Jones; M D Wilkie; A Lau; N S Upile; Jon Sheard; J Lancaster; S Tandon; M Robinson; D Husband; I Ganly; J P Shah; D M Brizel; B O'Sullivan; J A Ridge; W M Lydiatt
Journal:  Oral Oncol       Date:  2016-09-23       Impact factor: 5.337

View more
  2 in total

1.  [Quality in the appraisal of head and neck sonography results in university hospitals-a random sample].

Authors:  J Künzel; A Bozzato; B P Ernst; T Fuhrmann; I Ugele; C Scherl; M Schapher; G F Volk; N Mansour; A Knopf; C Bohr; K-F Hamann
Journal:  HNO       Date:  2021-01-13       Impact factor: 1.284

2.  Establishment and Validation of a Comprehensive Prognostic Model for Patients With HNSCC Metastasis.

Authors:  Yajun Shen; Lingyu Li; Yunping Lu; Min Zhang; Xin Huang; Xiaofei Tang
Journal:  Front Genet       Date:  2021-07-12       Impact factor: 4.599

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.